TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update
Go back to TransCode Therapeutics Reports First Quarter 2022 Results; Provides Business Update| (NASDAQ: RNAZ) | Delayed: 2.87 -0.1 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.97 | 52 Week High | $ | |||
| Open | $2.90 | 52 Week Low | $ | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.87 | EPS | $ | |||
| Volume | 38,973 | |||||

